Clinical Research Division, Fred Hutch
Dr. Kate Markey studies the intersection between the microorganisms in patients' intestines — the gut microbiome — the immune system, and the outcomes of immune-based cancer treatments. These include bone marrow transplantation and cellular immunotherapies. One focus area of her research is graft-vs.-host disease, or GVHD, in which immune cells from the donor attack the patient's healthy cells. She is learning how the microbiome interacts with the immune system to influence the development of GVHD and the effectiveness of transplant in controlling cancer. Dr. Markey is also a physician who cares for patients undergoing transplant. She uses data and observations from the clinic to inform her laboratory research, which in turn is aimed at improving patient care.
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
Masters in Clinical Research, Monash University, Australia, 2019
Ph.D. in Immunology, University of Queensland, Australia, 2011
M.B., B.S, University of Queensland, Australia, 2010
B. Engineering (Chemical), University of Queensland, Australia, 2004
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210